Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018
- PMID: 35089480
- DOI: 10.1007/s11060-022-03948-2
Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018
Abstract
Purpose: Postoperative epilepsy is common in glioma patients and has been suggested to indicate disease progression, yet knowledge of its role as a prognostic factor is limited. This study investigates the association between postoperative epilepsy and survival amongst patients with gliomas.
Methods: We included 3763 patients with histopathologically diagnosed grade II, III, and IV gliomas from 2009 to 2018 according to the Danish Neuro-Oncology Registry. Information on epilepsy diagnosis was redeemed from the Danish National Patient Registry, the National Prescription Registry and the Danish Neuro-Oncology Registry. We used Cox proportional hazards models with 95% confidence intervals (CIs) to examine hazard ratios (HRs) for the association between postoperative epilepsy and risk of death. We examined the role of the timing of epilepsy in three different samples: Firstly, in all glioma patients with postoperative epilepsy; secondly, in patients with postoperative de novo epilepsy; thirdly, exclusively in a homogeneous sub-group of grade IV patients with postoperative de novo epilepsy.
Results: Glioma patients with postoperative epilepsy had an increased risk of death, regardless of prior epilepsy status (HR = 4.03; CI 2.69-6.03). A similar increase in the risk of death was also seen in patients with postoperative de novo epilepsy (HR = 2.08; CI 1.26-3.44) and in the sub-group of grade IV patients with postoperative de novo epilepsy (HR = 1.83; CI 1.05-3.21).
Conclusions: Postoperative epilepsy may negatively impact survival after glioma diagnosis, regardless of preoperative epilepsy status. Postoperative epilepsy may be an expression of a more invasive growth pattern of the gliomas following primary tumor treatment.
Keywords: Epilepsy; Glioma; Grade; Postoperative; Survival.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Englot DJ, Berger MS, Barbaro NM, Chang EF (2011) Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg 115:240–244. https://doi.org/10.3171/2011.3.JNS1153 - DOI - PubMed
-
- Bonney PA, Boettcher LB, Burks JD et al (2017) Rates of seizure freedom after surgical resection of diffuse low-grade gliomas. World Neurosurg 106:750–756. https://doi.org/10.1016/j.wneu.2017.06.144 - DOI - PubMed
-
- Neal A, Morokoff A, O’Brien TJ, Kwan P (2016) Postoperative seizure control in patients with tumor-associated epilepsy. Epilepsia 57:1779–1788. https://doi.org/10.1111/epi.13562 - DOI - PubMed
-
- Kerkhof M, Vecht CJ (2013) Seizure characteristics and prognostic factors of gliomas. Epilepsia 54:12–17. https://doi.org/10.1111/epi.12437 - DOI - PubMed
-
- Chaichana KL, Parker SL, Olivi A, Quiñones-Hinojosa A (2009) Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article. J Neurosurg 111:282–292. https://doi.org/10.3171/2009.2.JNS081132 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
